Rollout of Covid vaccines is bumpy — but not unexpected

People are facing more challenges getting one of the updated shots than they may have experienced since the very first vaccination campaign.

September 26, 2023 Check out STAT+

Sponsored By

Eraldo Peres/AP Rollout of Covid vaccines is bumpy, but not unexpected, experts say Reality sets in with vaccine launch not part of a government emergency response. Insurance issues mount, prices rise, demand up for Covid booster shots. By Helen Branswell STAT+ | With Menendez indictment, pharmaceutical industry could lose a key ally Sen. Bob Menendez (D-N.J.), who's embroiled in a financial scandal, is one of the pharmaceutical industry's top Democratic allies. By Sarah Owermohle Nurses and health care support workers at higher risk of suicide, study finds The mental health toll of working in health care hits registered nurses and support workers, especially women, harder than physicians. By Annalisa Merelli Adobe Dairy farmers are running out of chances to kill the terms 'oat milk' and 'soy milk' Dairy farmers are running out of chances to kill terms like "almond milk." The last resort: asking Congress to overrule the FDA on the issue. By Nicholas Florko STAT+ | Medicare Advantage plans for dual-eligible enrollees set to get Senate scrutiny "Worse outcomes despite spending more money." Senators want to cut confusion on Medicare Special Needs Plans (SNP), a profit-driver for health insurers. By Simar Bajaj STAT+ | Intercept, once a biotech trailblazer, sells itself for less than $1 billion Alfasigma, an Italian pharmaceutical firm, will pay $19 a share for Intercept, in a roughly $800 million cash deal. By Damian Garde Adobe STAT+ | Just how much money do drugmakers gain from patent extensions? Four blockbuster drugs — Humira, Avastin, Rituxan, and Lantus — made 56% of their overall revenue after the end of their initial patents. By Annalisa Merelli

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser